Sentence examples for microarray technology such from inspiring English sources

The chapter outlines the human neurological diseases studied by microarray technology, such as multiple sclerosis, brain tumors, neuromuscular disorders, and alzheimer's disease.

In the early years of microarray technology, such an application could be possible; however, in practice, the expressional changes are often confirmed by other methods or by a different level of observations such as enzymatic activities, even in such experiments.

We have also provided alpha and beta testing services to companies that are introducing new microarray technologies, such as novel detection systems and data-analysis tools.

Novel microarray technologies such as the AB1700 platform from Applied Biosystems promise significant increases in the signal dynamic range and a higher sensitivity for weakly expressed transcripts.

Microarray technologies such as the Affymetrix Genechip® platform facilitate rapid measurement of the expression levels of thousands of transcripts in a single experiment and allow comparison of expression patterns across many samples [ 8].

The development of microarray technologies, such as array comparative genomic hybridization (array-CGH) and whole-genome SNP genotyping technologies, has enhanced the study of human SVs at the genome-wide level by detecting gains and losses of DNA regions compared to the reference genome [ 12- 14].

The development of cDNA microarray technology has provided such an opportunity.

As such, microarray technology provides a promising alternative to the Northern blot as numerous miRNAs can be analyzed at once with relatively minimal amount of initial RNA investment [ 23].

Other microarray-based technologies, such as comparative genomic hybridisation that provides a genome-wide survey of copy number changes, have also been utilised to study relationship between surgical outcome and biological factors.

With the assistance of high-throughput technology, such as microarray technology, several researchers have attempted to decipher the regulatory networks of bZIP TFs [ 4- 7].

With the rapid development of high-throughput screen (HTS) technology such as microarray, the superiority of systems biology and network pharmacology gradually embodied [ 7, 8].